Hand Eczema
18
1
3
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.6%
1 terminated out of 18 trials
90.0%
+3.5% vs benchmark
28%
5 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (18)
Methotrexat to Hand Eczema in the BIOSKIN Cohort
Prevention of Hand Eczema Among Workers in the Fishing Industry in Greenland
Topical Ruxolitinib Evaluation in Chronic Hand Eczema
Immune Signature of Chronic Hand Eczema Unveiled by Spatial Transcriptomics and Single-Cell Proteomics
LEO19123 Cream in the Treatment of Hand Eczema
Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema
A 24-week Single-blind Trial of Prevention of Hand Eczema in Cleaners
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1
Dupilumab in Severe Chronic Hand Eczema
Satisfaction Survey - Cicaplast Mains
Hand Eczema in the Health Care Sector
Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic
Treatment of Staphylococcus Aureus Colonization in Hand Eczema
A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema
Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema
Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand Eczema
Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis
A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema